COMP <GO>
PM vs ABBV // FORWARD P/E MULTIPLE
Philip Morris International Inc (NYSE) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: PM 8
— ABBV 7
▲ FORWARD P/E MULTIPLE LEADER: PM
LAST: $208.79 (+0.14%) • MKT CAP: $324.98B
forward-pe
26.6x
LAST: $294.89 (+1.41%) • MKT CAP: $513.86B
forward-pe
113.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PM VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PM | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 67.10% | 70.20% | -3.10 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 45.30% | 29.00% | +16.30 | PM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.7x | 33.3x | -11.60 | PM | /valuation <GO> |
| Free Cash Flow Yield | 3.28% | 3.47% | -0.19 | ABBV | /fcf-yield <GO> |
| Operating Margin | 36.60% | 24.60% | +12.00 | PM | /operating-margins <GO> |
| Net Profit Margin | 27.90% | 6.90% | +21.00 | PM | /net-margins <GO> |
| Revenue Growth (YoY) | 7.30% | 8.60% | -1.30 | ABBV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.65% | 2.27% | +0.38 | PM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.52 | 5.33 | -0.81 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | PM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 7.40% | -0.70 | PM | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.5 | 72.8 | -8.29 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 1.15 | -0.22 | ABBV | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 26.6x | 113.1x | -86.50 | PM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $324.98B | $513.86B | -$188.88B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PM REV | ABBV REV | PM GROSS % | ABBV GROSS % | PM FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $40.65B | $61.16B | 67.1% | 70.2% | $10.66B | $17.82B |
| FY 2024 | $37.88B | $56.33B | 64.8% | 70.0% | $10.77B | $17.83B |
| FY 2023 | $35.17B | $54.32B | 44.0% | 44.0% | $7.62B | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PM // BETA 0.93
ABBV // BETA 1.15